Acetylcarnitine and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Acetylcarnitine (acetyl - l - carnitine), especially for people who are female, 60+ old, also take Vitamin D3, and have Polymyositis.

The phase IV clinical study analyzes which people have Drowsiness when taking Acetylcarnitine. It is created by eHealthMe based on reports of 413 people who have side effects when taking Acetylcarnitine from the FDA, and is updated regularly.

What is Acetylcarnitine?

Acetylcarnitine has active ingredients of acetyl - l - carnitine. eHealthMe is studying from 418 Acetylcarnitine users. Check the latest studies of Acetylcarnitine.

What is Drowsiness?

Drowsiness is found to be associated with 2,865 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Jul, 22, 2026

413 people reported to have side effects when taking Acetylcarnitine.
Among them, 17 people (4.12%) have Drowsiness.

Among these 17 people:

What is the gender of people who have Drowsiness when taking Acetylcarnitine? *

female: 64.71 %
male: 35.29 %

What is the age of people who have Drowsiness when taking Acetylcarnitine? *

What are other drugs people take besides Acetylcarnitine? *

What are other side effects people have besides Drowsiness? *

Fatigue (feeling of tiredness): 10 people, 58.82%
Dizziness: 6 people, 35.29%
Weakness: 5 people, 29.41%
Memory Loss: 5 people, 29.41%
Visual Impairment: 4 people, 23.53%
Urination - Excessive At Night: 4 people, 23.53%
Dyspnea (difficult or laboured breathing): 4 people, 23.53%
Cardiac Disorder: 4 people, 23.53%
Diarrhea: 4 people, 23.53%
Back Pain: 4 people, 23.53%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 11.76%
Non-Small Cell Lung Cancer Stage Iv: 2 people, 11.76%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 2 people, 11.76%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.76%
Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 11.76%
Multiple Myeloma (cancer of the plasma cells): 2 people, 11.76%
Lung Carcinoma Cell Type Unspecified Stage 0 (the lung cancer has not spread beyond the inner lining of the lung): 2 people, 11.76%
Prostate Cancer: 2 people, 11.76%
Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 2 people, 11.76%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Acetylcarnitine and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acetylcarnitine:

Acetylcarnitine (418 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

Browse all side effects of Acetylcarnitine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,865 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,797 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetyl - l - carnitine (the active ingredients of Acetylcarnitine) and Acetylcarnitine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.